Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-15
H
Hannah E. Shaw
Researcher
Also affiliated: University of Maryland, Baltimore (2024)
Unknown Researcher
4 h-index
7 pubs
25 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Hannah E. Shaw researches the pharmacological effects and abuse potential of various psychoactive substances in animal models. Her work investigates the antinociceptive, dependence, and withdrawal effects of novel synthetic opioids like furanyl fentanyl and acryl fentanyl in mice. Shaw also studies the abuse liability and neurocognitive effects of arylcyclohexylamine drugs, as well as the impact of synthetic cannabinoid receptor agonists on fentanyl-induced respiratory depression and naloxone efficacy. Additionally, her research explores the effects of psychedelics, such as lysergic acid diethylamide and DOI, on opioid consumption and withdrawal in mice, and the influence of psychostimulants on locomotor activity in mouse models relevant to autism spectrum disorder and ADHD. Shaw has published six papers and has an h-index of 4, with a total of 23 citations. She has collaborated with several researchers at the University of Arkansas for Medical Sciences, including William E. Fantegrossi on five shared publications.
Metrics
- h-index: 4
- Publications: 7
- Citations: 25
Selected Publications
-
Interoceptive effects of N1-substituted lysergamides in rats: role of agonist affinity at 5-HT receptors and in vivo metabolism to lysergic acid diethylamide (LSD) (2026)
-
Effects of Psychedelics Lysergic Acid Diethylamide and <i>R</i> (–)-2,5-Dimethoxy-4-Iodoamphetamine on Oral Opioid Consumption and Naloxone-Precipitated Withdrawal in Male C57Bl/6J Mice (2026)
-
Effects of psychostimulants on locomotor activity in the BTBR T+ Itpr3tf/J mouse: implications for comorbid autism spectrum disorder and attention deficit hyperactivity disorder (2025)
-
Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption (2025)
-
Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice (2025)
-
Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents (2024)
-
Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder (2023)
Collaboration Network
Top Collaborators
William E. Fantegrossi
University of Arkansas for Medical Sciences
5 shared publications
In database
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
- Effects of psychostimulants on locomotor activity in the BTBR T+ Itpr3tf/J mouse: implications for comorbid autism spectrum disorder and attention deficit hyperactivity disorder
- Effects of Psychedelics Lysergic Acid Diethylamide and <i>R</i> (–)-2,5-Dimethoxy-4-Iodoamphetamine on Oral Opioid Consumption and Naloxone-Precipitated Withdrawal in Male C57Bl/6J Mice
Brenda M. Gannon
University of Arkansas for Medical Sciences
3 shared publications
In database
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
- Effects of Psychedelics Lysergic Acid Diethylamide and <i>R</i> (–)-2,5-Dimethoxy-4-Iodoamphetamine on Oral Opioid Consumption and Naloxone-Precipitated Withdrawal in Male C57Bl/6J Mice
Marina Avram
Arkansas Department of Agriculture
2 shared publications
In database
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
Jeffery H. Moran
Arkansas Department of Agriculture
2 shared publications
In database
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
Dylan R. Patel
University of Arkansas for Medical Sciences
1 shared publication
In database
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
Lauren R. Fitzgerald
University of Arkansas for Medical Sciences
1 shared publication
In database
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
Theresa M. Carbonaro
United States Department of Justice
1 shared publication
In database
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
Chad R. Johnson
University of Maryland, Baltimore (US)
1 shared publication
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
J S James
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
Jessica Thrush
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
Taher M Yusufali
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthetic cannabinoid receptor agonists exacerbate fentanyl-elicited respiratory depression and confer resistance to naloxone rescue in mice
Mary E Shepard
University of Arkansas for Medical Sciences
1 shared publication
In database
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
Justin Pressley
University of Arkansas for Medical Sciences
1 shared publication
In database
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
Kristina Wolf
University of Kentucky (US)
1 shared publication
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
Stephen A. Fagot
University of Arkansas for Medical Sciences
1 shared publication
In database
- Effects of psychostimulants on locomotor activity in the BTBR T+ Itpr3tf/J mouse: implications for comorbid autism spectrum disorder and attention deficit hyperactivity disorder
Similar Researchers
Based on overlapping research topics
Heidi D. Hughes-Meredith
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Neuroscience and Neuropharmacology Research
W. Brooks Gentry
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Neuroscience and Neuropharmacology Research
Catheryn D. Wilson
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Neuroscience and Neuropharmacology Research
Melinda G. Gunnell
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Neuroscience and Neuropharmacology Research
John T. Striednig
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Neuroscience and Neuropharmacology Research
Mary E Shepard
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Neuroscience and Neuropharmacology Research